Cormorant Asset Management

Latest statistics and disclosures from Cormorant Asset Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 48 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Moonlake Immunotherapeutics Class A Ord (MLTX) 24.5 $513M +4% 8.5M 60.39
 View chart
Ambrx Biopharma 7.6 $160M NEW 11M 14.24
 View chart
Eyepoint Pharmaceuticals Com New (EYPT) 6.7 $140M +88% 6.0M 23.11
 View chart
Bridgebio Pharma (BBIO) 6.4 $135M -28% 3.3M 40.37
 View chart
Arcellx Common Stock (ACLX) 4.5 $94M -20% 1.7M 55.50
 View chart
Rayzebio (RYZB) 3.6 $75M +2% 1.2M 62.17
 View chart
Biomea Fusion (BMEA) 2.5 $52M 3.6M 14.52
 View chart
Immunovant (IMVT) 2.3 $49M -4% 1.2M 42.13
 View chart
Alpine Immune Sciences (ALPN) 2.3 $49M +34% 2.6M 19.06
 View chart
Pharvaris N V (PHVS) 2.3 $48M +25% 1.7M 28.05
 View chart
Alx Oncology Hldgs (ALXO) 2.2 $47M +413% 3.1M 14.89
 View chart
Tarsus Pharmaceuticals (TARS) 2.1 $45M -15% 2.2M 20.25
 View chart
Cymabay Therapeutics (CBAY) 2.0 $43M -53% 1.8M 23.62
 View chart
Vaxcyte (PCVX) 2.0 $42M 665k 62.80
 View chart
Crinetics Pharmaceuticals In (CRNX) 2.0 $41M +4% 1.2M 35.58
 View chart
Apellis Pharmaceuticals (APLS) 1.8 $37M -68% 625k 59.86
 View chart
Marinus Pharmaceuticals Com New (MRNS) 1.7 $35M +23% 3.3M 10.87
 View chart
Autolus Therapeutics Spon Ads (AUTL) 1.7 $35M +1289% 5.5M 6.44
 View chart
Olema Pharmaceuticals (OLMA) 1.6 $35M -45% 2.5M 14.03
 View chart
Immuneering Corp Class A Com (IMRX) 1.5 $31M 4.2M 7.35
 View chart
Edgewise Therapeutics (EWTX) 1.3 $28M -13% 2.6M 10.94
 View chart
Aerovate Therapeutics (AVTE) 1.3 $27M -22% 1.2M 22.63
 View chart
Cargo Therapeutics 1.3 $27M NEW 1.2M 23.15
 View chart
Syndax Pharmaceuticals (SNDX) 1.2 $25M NEW 1.2M 21.61
 View chart
Korro Bio 1.2 $25M NEW 529k 47.93
 View chart
Rhythm Pharmaceuticals (RYTM) 1.2 $25M -35% 550k 45.97
 View chart
Abivax Sa Sponsored Ads 1.1 $23M NEW 2.1M 10.70
 View chart
Harpoon Therapeutics Com New (HARP) 1.1 $23M +4245% 2.3M 9.60
 View chart
Spyre Therapeutics Com New (SYRE) 1.0 $20M NEW 937k 21.52
 View chart
Insmed Com Par $.01 (INSM) 0.9 $18M 575k 30.99
 View chart
Ideaya Biosciences (IDYA) 0.8 $16M -25% 450k 35.58
 View chart
Axonics Modulation Technolog (AXNX) 0.7 $16M 250k 62.23
 View chart
Neurogene 0.7 $15M NEW 746k 19.38
 View chart
Longboard Pharmaceuticals In (LBPH) 0.7 $14M 2.4M 6.03
 View chart
Praxis Precision Medicines I Com New 0.7 $14M NEW 633k 22.28
 View chart
Rocket Pharmaceuticals (RCKT) 0.6 $14M 450k 29.97
 View chart
Rapt Therapeutics (RAPT) 0.6 $12M +52% 497k 24.85
 View chart
Disc Medicine (IRON) 0.3 $7.2M -44% 125k 57.76
 View chart
Stoke Therapeutics (STOK) 0.3 $5.7M 1.1M 5.26
 View chart
Editas Medicine Put Option (EDIT) 0.2 $5.1M NEW 500k 10.13
 View chart
Verve Therapeutics (VERV) 0.2 $4.9M 350k 13.94
 View chart
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) 0.2 $4.7M NEW 75k 62.00
 View chart
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.2 $4.5M 562k 7.96
 View chart
Biohaven (BHVN) 0.2 $3.5M 82k 42.80
 View chart
Gh Research Ordinary Shares (GHRS) 0.2 $3.4M 593k 5.80
 View chart
Vyne Therapeutics (VYNE) 0.2 $3.2M NEW 1.4M 2.33
 View chart
Bioatla (BCAB) 0.1 $2.9M 1.2M 2.46
 View chart
Neumora Therapeutics (NMRA) 0.1 $1.6M 92k 17.05
 View chart

Past Filings by Cormorant Asset Management

SEC 13F filings are viewable for Cormorant Asset Management going back to 2013

View all past filings